Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Creating a Digital Patient Journey in Healthcare

The creation of a digital patient journey in healthcare represents a significant step forward in enhancing the patient experience and overall quality of care. In this episode of Dash Talk, The Becker’s Healthcare Podcast host, Laura Dyrda sat down with David Dyke, Chief Product Officer at Relatient, and Arun Mohan, President of Relatient. Together, they…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

The creation of a digital patient journey in healthcare represents a significant step forward in enhancing the patient experience and overall quality of care. In this episode of Dash Talk, The Becker’s Healthcare Podcast host, Laura Dyrda sat down with David Dyke, Chief Product Officer at Relatient, and Arun Mohan, President of Relatient. Together, they discuss the role of scheduling in defining elite customer experience.

Between staying on hold, finding an ideal location, and checking for availability, scheduling a healthcare appointment can be a very tedious process. “Anyone who has tried to schedule an appointment knows how hard it is,” says Mohan. However, this is just as hard for doctors and medical groups, and the challenge is not all doctors are created equal. “You got to simplify a lot of the underlying workflows and operations to make it possible.”

When you have something complicated like scheduling, there is traditionally a very steep learning curve in becoming familiar with factors such as locations and rules. “There’s generally a physical binder or Sharepoint slides that are constantly being updated,” Dyke explains, “so one of the things that folks are looking for is technology to help their newest scheduler be as effective as their senior scheduler.”

Creating a digital patient journey eases the burden of scheduling on providers and staff; however, the deployment of an online scheduling system is a fairly difficult process. “We are really trying to help our customers deliver the right balance between precision scheduling and patient-friendly scheduling,” Dyke explains.

In a recent survey, they found patients love self-scheduling when it works and asks for information that is readily known. “If you start asking secondary and tertiary additional questions we see a really significant drop-off point,” Dyke explains. Focusing on the things that matter most, such as allowing the patient to book and confirm an appointment, is vital in a digital patient journey.

When asked how health systems can improve the digital patient’s journey, Dyke and Mohan provide two factors: focusing on access and integrating a digital patient journey into every activity.

“One of the most important considerations in how you select a provider is convenience and availability,” Mahon explained. When considering how to do this for provider groups, the answer is multi-faceted. Moreover, integrating these into every activity is vital as well. “A good example of this is recall management,” says Mahon.

Tune in to learn more about all of the factors that go into creating a seamless, elite scheduling experience for both patients and providers in healthcare.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended AstraZeneca and Daiichi Sankyo’s Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly is investing $6.5 billion in a Houston manufacturing facility set to open around 2030, primarily to scale production of Foundayo, its oral GLP-1 treatment. The project signals a broader shift in U.S. pharmaceutical manufacturing reshoring and underscores the supply chain challenge of forecasting demand and building capacity years in advance for breakthrough therapeutics.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain: Lilly's CEO noted that one-third of new GLP-1 pill patients are now choosing Foundayo, illustrating fast-moving market share shifts that complicate production planning years in advance
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

Waiting for perfectly clean data is stalling healthcare AI, not protecting it

Healthcare organizations often delay AI initiatives waiting for perfectly clean data, but this assumption no longer holds: reliable subsets and synthetic data allow projects to start now while data work continues in parallel. Success requires starting with business outcomes rather than technology capabilities, and embedding governance in product strategy before implementation, not after.

  • 01Waiting for 100% clean data is effectively a decision never to start; hospital AI projects can begin on reliable data subsets while quality work continues in parallel.
  • 02Frame AI decisions around business outcomes (revenue growth, cost reduction, competitive advantage, new products, or ecosystem influence) rather than asking what AI can do.
  • 03Governance should be part of product strategy before design or purchase, especially as agentic AI takes actions—such as handling many revenue-cycle denials—while routing the rest to humans.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512